New frontiers in men's sexual health: Understanding erectile dysfunction and the revolutionary new treatments

New Frontiers in Men's Sexual Health: Understanding Erectile Dysfunction and the Revolutionary New Treatments

Volumn , Issue , 2008, Pages 1-246

  Hanash, Kamal Anthony ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861382715     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (232)

1. Althof SE, et al. "Why do so many people drop out from auto-injection therapy for impotence?" J Sex Marital Ther 15:121-129, 1989.
2. Althof SE, et al. "Psychological and interpersonal dimensions of sexual function and dysfunction." Paper presented at the Second International Consultation on Erectile and Sexual Dysfunctions. Paris, June 28-July 1, 2003.
3. Althof SE, et al. "Psychological and interpersonal dimensions of sexual function and dysfunction." J Dex Med 2:793-800, 2005.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994.
5. Althof SE, et al. "Psychological and interpersonal dimensions of sexual function and dysfunction." J Dex Med 2:793-800, 2005.
6. Araujo AB, et al. "Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study." J Am Geriatr Soc 52:1502-1509, 2004.
7. Austoni E, et al. "A new technique for augmentation phalloplasty: albugineal surgery with bilateral saphenous grafts: three years of experience." Eur Urol 42:345-353, 2002.
8. Awwad Z, et al. "Penile measurements in normal adult Jordanians and in patients with erectile dysfunction." Int J Impot Res 17:191-195, 2005.
9. Bannowsky A, et al. "Recovery of erectile function after nerve sparing prostatectomy- improvement with nightly low dose sildenafil." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
10. Bansal TC, et al. "Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction." J Sex Med 2:96-103, 2005.
11. Barada J, McCullough AR. "Premature ejaculation: increasing recognition and improving treatment." MD Medscape Today, June 2, 2004, htt://bcbsma.medscape.com/ viewprogram/3131.
12. Basson R, et al. [No title]. Paper presented at the Second International Consultation on Erectile and Sexual Dysfunctions. Paris, June 28-July 1, 2003.
13. Bayer-Glaxo Co. "Vardenafil hydrochloride (Levitra)." U.S. prescribing information, 2003.
14. Becker AJ, et al. "Therapy of organic erectile dysfunction" (in German). Urologe A 44: 1160-1166, 2005.
15. Beheri GE, "Surgical treatment of impotence." Plas. Reconst Surgery 38:92-97, 1966.
16. Bella AJ, et al. "Non-palpable scarring of the penile septum as a cause of ED: an atypical form of Peyronie's disease." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
17. Bennett AH. "Revascularization using the dorsal vein of the penis in vasculogenic impotence." Semin Urol 4:259-262, 1986.
18. Benson CB, Vickers MA. "Sexual impotence caused by vascular disease: diagnosis with duplex sonography." Am J Roenthenol 153:1149-1153, 1989.
19. Blanker MH, et al. "Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study." J Am Geriatr Soc 49:436-442, 2001.
20. Blundell N. The World 's Greatest Scandals of the Twentieth Century. London: Hamlyn/Reed Octopus Publishing Gray Ltd., pp. 137-139, 1994.
21. Bondil P, et al. "Educational, socio-cultural and ethical aspects of sexual dysfunction." Paper presented at the Second International Consultation on Erectile and Sexual Dysfunctions. Paris, June 28-July 1, 2003.
22. Bookstein JJ, et al. "Pharmacoangiographic assessment of the corpora cavernosa." Cardiovasc Intervent Radiol 11:218-224, 1988.
23. Brandstetter K, et al. "Color duplex sonography of the penis-examination technique and clinical results." Bildgebung 58:42-44, 1991.
24. Brant MD, et al. "The prosthesis salvage operation: immediate replacement of the infected penile prosthesis." J Urol 155:155-157, 1996.
25. Braun M, et al. "Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey.' " Int J Impot Res 12:305-311, 2000.
26. Brinkman MJ, et al. "A survey of patients with inflatable penile prostheses for satisfaction." J Urol 174:352-357, 2005.
27. Brissard E. "How to become a multiorgasmic man?" (in French). Psychologies 8:55, 2006.
28. Brisson TE, et al. "Vardenafil rescue rates of sildenafil nonresponders: objective assessment of 327 patients with erectile dysfunction." Urology 68:397-401, 2006.
29. Broderick GA, et al. "The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. J Urol 147:57-61, 1992.
30. Cappelleri JC, Rosen RC. "The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience." Int J Impot Res 17:307-319, 2005.
31. Carson CC, Lue TF. "Phosphodiesterase type 5 inhibitors for erectile dysfunction." BJU Int 96:257-268, 2005.
32. Carson CC, et al. "The 'effectiveness' scale-therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report." Int J Impot 16:207-213, 2004.
33. Carson CC, et al. "Erectile dysfunction: new concepts in diagnosis, prevention, and management." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
34. Cavallini G, et al. "Oral propionyl-1-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease." BJU Int 89:895-900, 2002.
35. Chen J, et al. "Predicting penile size during erection." Int J Impot Res 12:328-333, 2000.
36. Chen KL, et al. "Total corpora replacement for erectile dysfunction." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
37. Chia SJ, et al. "Clinical application of prognostic factor for patients with organic causes of erectile dysfunction on 100 mg of sildenafil citrate." Int J Urol 11:1104-1109, 2004.
38. Corona G, et al. "Aging and pathogenesis of erectile dysfunction." Int J Impot Res 16:395-402, 2004.
39. Cutler WB, et al. "Pheromonal influences in sociosexual behavior." Arch Sex Behav 27:113, 1998.
40. De Amicis LA, et al. "Clinical follow up of couples treated for sexual dysfunction." Arch Sex Behav 14:467-489, 1985.
41. Dean J, et al. "Is premature ejaculation all in the mind?" Br J Urol 96:234-236, 2005.
42. De Berardis G, et al. "Clinical and psychological predictors of self reported erectile dysfunction in patients with type 2 diabetes." J Urol 177:252-257, 2007.
43. De Boer BJ, et al. "The prevalence of bother, acceptance, and need for help in men with erectile dysfunction." J Sex Med 2:445-450, 2005.
44. De la Taille A, et al. "Reasons for drop-out from short and long-term self injection therapy for impotence." Eur Urol 35:312-317, 1995.
45. Diemer T, et al. "Therapy of the aging male" (in German). Urologe A 44:1173-1178, 2005.
46. Dorland 's Illustrated M Dictionary. 28th ed. Philadelphia: W. B. Saunders, 1994.
47. Dunajska K, et al. "Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis." Aging Male 7:197-204, 2004.
48. Eardley I. "Vardenafil: a new oral treatment for erectile dysfunction." Int J Clin Pract 58:801-806, 2004.
49. Eardley I. "A closer look at the PDE-5 inhibitors (course)." Paper presented at the European Association of Urology Meeting. Istanbul, Turkey, March 16-19, 2005.
50. Eardley I, et al. "An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase- 5 inhibitor therapy." Br J Urol Int 96:1323-1332, 2005.
51. Eardley I, et al. "Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open label, crossover study." Br J Urol Int 100:122-129, 2007.
52. Ebstein RP. "Sexual desire is in your genes: Israeli research." ScienceNewsDen.com, 2006, http://www.sciencenewsden.com/2006/sexualdesireisinyourgenes.shtml.
53. Fallon B. "Intracavernous injection therapy for male erectile dysfunction." Urol Clin North Am 22:833-845, 1995.
54. Fantini GV, et al. "Microvascular arterial bypass surgery: assessment of long-term outcome." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
55. Feldman HA, et al. "Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study." J Urol 151:54-61, 1994.
56. Frajese GV, Pozzi F. "New achievements and novel therapeutic applications of PDE-5 inhibitors in older males." J Endocrinol Invest 28:45-50, 2005.
57. Francken AB, et al. "What importance do women attribute to the size of the penis?" Eur Urol 42:426-431, 2002.
58. Furlow WL, Fisher J, Knoll LD, et al. "Current status of penile revascularization with deep dorsal vein arterialization. Experience with 95 patients." Int J Impotence Res 2:348-349, 1990.
59. Gallo L, et al. "Recovery of erection after pelvic urologic surgery: our experience." Int J Impot Res 17:45-48, 2005.
60. Gaylis FD, et al. "Prostate cancer in men using testosterone supplementation." J Urol 174:534-538, 2005.
61. Gelbard MK, et al. "The natural history of Peyronie's disease." J Urol 144:1376-1379, 1990.
62. Gemery JM, et al. "3D digital modeling of male pelvis on bicycle seats: impact of rider position and seat design on potential hypoxia and ED." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
63. Gerstenberg TC, et al. "Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure." J Urol 147:1277-1279, 1992.
64. Gholami SS, et al. "The effect of vascular endothelial growth factor and adeno-associated virus-mediated brain-derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia." J Urol 169:1577-1581, 2003.
65. Goldmeier D, Green PE. "Pheromones = the smell of sexual desire." Sex Dysfunc 1:119-121, 1998.
66. Greenfield JM, et al. "Verapamil versus saline in electromotive drug administration (EDMA) for Peyronie's disease: a double blind controlled trial." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
67. Gutierrez P, et al. "Combining programmed intracavernous PGE1 injections and sildenafil on demand to salvage sildenafil nonresponders." Int J Impot Res 17:354-358, 2005.
68. Hanash KA. "Comparative results of goal-oriented therapy for erectile dysfunction." J Urol 157:2135-2139, 1997.
69. Hanash KA, et al. Perfect Lover: A Guide for Enhancing Everyone's Sex Life. New York: SPI Books, 1994.
70. Harding R, Colombok SE. "Test-retest reliability of the measurement of penile dimensions in a sample of gay men." Arch Sex Behav 31:351-357, 2002.
71. Hatzichristou D, et al. "Effect of tadalafil on sexual timing behavior patterns in men with ED: integrated analysis of randomized placebo controlled trials." J Urol 174: 1356-1359, 2005.
72. Hatzimouratidis K, Hatzichristou DG. "A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?" Drugs 65:1621-1650, 2005.
73. Hatzimouratidis K, Hatzichristou DG. "Looking to the future for erectile dysfunction therapies." Drugs 68:231-250, 2008.
74. Havelock E. Little Essays of Love and Virtue. London: A & C Black, 1922.
75. Hellstrom WJG, et al. "Current safety and tolerability issues in men with erectile dysfunction receiving PDE-5 inhibitors." Int J Clin Pract 61:1547-1554, 2007.
76. Henry GD, et al. "Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study." J Urol 173:89-92, 2005.
77. Herwig R, et al. "Pelvic venoablation with air-block aetoxysclerol for the treatment of erectile dysfunction caused by venous leakage." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
78. Hutter AM, Jr. "Role of the cardiologist: clinical aspects of managing erectile dysfunction." Clin Cardiol 27:13-17, 2004.
79. Israilov S, et al. "Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus." Int J Impot Res 17:431-436, 2005.
80. Jannsen E, et al. "Automatic process and the appraisal of sexual stimuli: toward an information-processing model of sexual arousal." J Sex Res 37:8-23, 2000.
81. Jarrow JP, et al. "Course on male sexual dysfunction: practice management guidelines." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
82. Johannes CB, et al. "Incidence of erectile dysfunction in men 40 to 69 years old: prospective results from the Massachusetts Male Aging Study." J Urol 163:460-463, 2000.
83. Kaiser FE, Korenman SG. "Erectile dysfunction in diabetic men." JAMA 85(suppl 5A):147-150, 1988.
84. Kalmuss D. "Nonvolitional sex and sexual health." Arch Sex Behav 33:197-209, 2004.
85. Kawanishi Y, et al. "Penile revascularization surgery for arteriogenic erectile dysfunction: the long-term efficacy calculated by survival analysis." Br J Urol Int 94:361-366, 2004.
86. Kendira M, et al. "The impact of various risk factors on penile hemodynamics in men with ED." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
87. Kendirci M, et al. "The impact of vascular risk factors on erectile function." Timely Top Med Cardiovasc Dis 1:E11, 2005.
88. Kinsey AC, et al. Sexual Behavior in the Human Male. Philadelphia: W. B. Saunders, 1948.
89. Klotz T, et al. "Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)?" Int J Impot Res 17:2-4, 2005.
90. Kocakok E, et al. "Effects of sildenafil on major arterial blood flow in duplex sonography." J Clin Ultrasound 33:173-175, 2005.
91. Kostis JB, et al. "Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)." Am J Cardiol 96:85M-93M, 2005.
92. Kratzik CW, et al. "Hormone profiles, body mass index and aging male symptoms: results of the Androx Vienna Municipality Study." Aging Male 7:188-196, 2004.
93. Kupelian V, et al. "Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study." J Urol 176:222-226, 2006a.
94. Kupelian V, et al. "The impact of sex hormones on erectile dysfunction: results of the Massachusetts Male Aging Study." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006b.
95. Latini DM, et al. "Psychological impact of erectile dysfunction: validation of a new health-related quality-of-life measure for patients with erectile dysfunction." J Urol 168:2086-2091, 2002.
96. Lau DH, et al. "Gene therapy and erectile dysfunction: the current status." Asian J Androl, 2008, in press.
97. Lee PA, Reiter EO. "Genital size: a common adolescent male concern." Adolesc Med 13:171-180, 2002.
98. Lehman K, et al. "Reasons for discontinuing intracavernous injection therapy with prostaglandin E1 (alprostadil)." Urology 53:397-400, 1999.
99. Lepore JJ, et al. "Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide." Chest 127:1647-1653, 2005.
100. Leslie SJ, et al. "No adverse hemodynamic reaction between sildenafil and red wine." Clin Pharmacol Ther 76:365-370, 2004.
101. Lever J, et al. "Does size matter? Men's and women's views on penis size across life span." Psychol Men Masculinity 3:129-143, 2006.
102. Levine LA, Estrada CR. "Intralesional verapamil for the treatment of Peyronie's disease: a review." Int J Impot Res 14:324-328, 2002.
103. Lewis R, et al. "Epidemiology/risk factors of sexual dysfunction." J Sex Med 1:35-39, 2004.
104. Lizza EF, Rosen RC. "Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research." Int J Impot Res 11:141-143, 1999.
105. Lobo JR, Nehra A. "Clinical evaluation of erectile dysfunction in era of PDE 5-inhibitors." Urol Clin North Am 32:447-455, 2005.
106. LoPicollo J. "Post-modern sex therapy for erectile failure." Nord Sexol 9:205-225, 1991.
107. Lue TF. "Male sexual dysfunction." In Smith's General Urology, pp. 803-805. New York: Lange Medical Books/McGraw-Hill, 2000.
108. Lue TF. "Adipose tissue derived stem cells and sexual medicine." Paper presented at the Third Biennial Conference of the Pan Arab Society for Sexual Medicine. Dubai, United Arab Emirates, February 8-11, 2007.
109. Lue TF, Tanagho EA. "Physiology of erection and pharmacological management of impotence." J Urol 137:829, 1987.
110. Lue T, et al. "Physiology of erection." In Clinical Manual of Sexual Medicine. Sexual Dysfunctions in Men, pp. 9-18. Paris: Health Publications, 2004a.
111. Lue TF, et al. "Summary of the recommendations on sexual dysfunctions in men." J Sex Med 1:6-23, 2004b.
112. Lue T, et al. "Intracorporeal pharmacological therapy." In Clinical Manual of Sexual Medicine. Sexual Dysfunctions in Men, pp. 39. Paris: Health Publications, 2004c.
113. Manikandan R, et al. "Evaluation of extracorporeal shock wave therapy in Peyronie's disease." Urology 60:795-79l, 2002. (Discussion, Urology 60: 799-800, 2002.)
114. Marshall Y. "The Rise of Viagra: How the Little Blue Pill Changed Sex in America, by Meika Loe" [Book Review] N Engl J Med 351:2776-2777, 2004.
115. Martinez-Jabaloyas JM, et al. "Testosterone levels in men with erectile dysfunction." Br J Urol Int 97:1278-1283, 2006.
116. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little-Brown, 1970.
117. McMahon CG, Meston C. "Definitions and Epidemiology of Sexual Dysfunction." Paper presented at the Second International Consultation on Erectile and Sexual Dysfunctions. Paris, June 28-July 1, 2003.
118. McMahon CG, Montorsi F. "Premature ejaculation: past, present, and future perspectives: introduction." Paper presented at the 11th World Congress of the International Society for Sexual and Impotence Research. Buenos Aires, Argentina, October 18-21, 2004.
119. McMahon CG, et al. "Disorders of orgasm and ejaculation in men." J Sex Med 1:58-65, 2004.
120. McMahon CG, et al. "Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review." Br J Urol Int 98:259-272, 2006.
121. McVary KT, et al. "Sildenafil improves erectile function and concomitant lower urinary tract symptoms in men." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
122. Melman A, et al. "Results of the first human trial for gene transfer therapy for the treatment of erectile dysfunction [Abstract 686]. J Urol 175:222, 2006.
123. Melman A, et al. "Gene transfer with a vector expressing Maxi-K from a smooth muscle specific promoter restores erectile function in the aging rat." Gene Ther 15:364-370, 2008.
124. Metin A, et al. "Does lidocaine ointment addition increase fluoxetine efficacy in the same group of patients with premature ejaculation?" Urol Int 75:231-234, 2005.
125. Meuleman EJH, Van Lankveld JDM. "Hypoactive sexual desire disorder: an underestimated condition in men." Br J Urol 95:291-296, 2004.
126. Meyer KF, et al. "Definitions and epidemiology of sexual dysfunction." Paper presented at the Second International Consultation on Erectile and Sexual Dysfunctions. Paris, June 28-July 1, 2003.
127. Mikhail N. "Does testosterone have a role in erectile dysfunction?" Am J Med 119:372-382, 2006.
128. Mirone V, et al. "An evaluation of an alternative dosing regimen with tadalafil, 3 time/week for men with erectile dysfunction: SURE study in 14 European countries." Eur Urol 47:846-854, 2005.
129. Mittleman MA, et al. "Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate." Am J Cardiol 96:443-446, 2005.
130. Mondaini N, Gontero P. "Idiopathic short penis: myth or reality?" Br J Urol Int 95:8-10, 2005.
131. Mondaini N, et al. "Penile size is normal in most men seeking penile lengthening procedures." Int J Impot Res 14:283-286, 2002.
132. Montague DK, et al. "AUA guidelines on the pharmacologic management of premature ejaculation." J Urol 172:290-294, 2004.
133. Montague DK, et al. "Erectile Dysfunction Guideline Update Panel. Chapter 1: The management of erectile dysfunction: an AUA update." J Urol 174:230-239, 2005.
134. Montorsi F. "Peyronie's disease-ESU course, medical and surgical management of erectile dysfunction." Paper presented at the European Association of Urology Meeting. Istanbul, Turkey, March 16-19, 2005.
135. Montorsi F, et al. "The ageing male and erectile dysfunction." Br J Urol Int 92:516-525, 2003.
136. Montorsi F, et al. "Erectile dysfunction predicts extension of coronary artery disease by angiography in acute coronary syndromes: the dead goose study." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
137. Morales A. "The andropause: bare facts for urologists." Br J Urol Int 91:311-313, 2003.
138. Morales A. "Testosterone and prostate health: Debunking myths demands evidence, caution and good judgment." European Urology 50:895-897, 2006.
139. Morales A, Heaton JPW. "Hypogonadism and erectile dysfunction: pathophysiological observations and therapeutic outcomes." Br J Urol Int 92:896-899, 2003.
140. Morelli A, et al. "Which patients with sexual dysfunction are suitable for testosterone therapy?" J Endocrinol Invest 30:880-888, 2007.
141. Mueller A, et al. "Analysis of predictors of erectile function outcomes with pharmacological penile rehabilitation following radical prostatectomy." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
142. Mukhergee B, Shivakumar T. "A case of sensorineural deafness following ingestion of Sildenafil." J Laryngol Otol 121:395-397, 2007.
143. Mykletun A, et al. "Assessment of male sexual function by the Brief Sexual Function Inventory." Br J Urol Int 97:316-323, 2006.
144. Nakanishi S, et al. "Erectile dysfunction is strongly linked with decreased libido in diabetic men." Aging Male 7:113-119, 2004.
145. Padmanabhan P, McCullough AR. "A pilot study to determine local oxygen saturation of the flaccid and erect penis in men with or without erectile dysfunction using a noninvasive tissue oximeter." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
146. Padma-Nathan H, Yeager JL. "An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients." Urology 68:386-391, 2006.
147. Panser LA, et al. "Sexual function of men ages 40 to 79 years: the Olmsted County study of urinary symptoms and health status among men." J Am Geriatr Soc 43:1107-1111, 1995.
148. Patel P. Sexuality: Perception and Performance throughout History. Lilly-ICOS, 2006.
149. Patrick DL, et al. "Premature ejaculation: an observational study of men and their partners." J Sex Med 2:358-367, 2005.
150. Patrick DL, et al. " 'He said/she said': comparing male and partner perceptions of premature ejaculation." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
151. Perelman MA. "Unveiling retarded ejaculation." J Urol 175(suppl 4), abstract 1337, 2006.
152. Perelman M, et al. "Attitudes of men with erectile dysfunction: a cross-national survey." J Sex Med 2:397-406, 2005.
153. Perovic S, et al. "Enlargement and sculpturing of a small and deformed penis." J Urol 170:1686-1690, 2003.
154. Perovic SV, et al. "New perspectives of penile enhancement surgery: tissue engineering with biodegradable scaffolds." Eur Urol 49:139-147, 2006.
155. Pickard RS, et al. "The role of color duplex ultrasonography in the diagnosis of vasculogenic impotence." Br J Urol 68:537-540, 1991.
156. Ponchietti R, et al. "Penile length and circumference: a study of 3,300 Italian males." Eur Urol 9:183-186, 2001.
157. Porst H, et al. "The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking." Eur Urol 26, doi: EUR UROL 51: 816-23, 2007, 2006.
158. Prins J, et al. "Prevalence of erectile dysfunction: a systematic review of population-based studies." Int J Impot Res 14:422-432, 2002.
159. "Proceedings of the First Latin American Erectile Dysfunction Consensus." Int J Impot Res 15(suppl 7):S1-S45, 2003.
160. Pryor J, et al. "Peyronie's disease." J Sex Med 1:110-115, 2004.
161. Raina R, et al. "Early combination therapy following radical prostatectomy (RP): intracorporeal alprostadil and sildenafil promotes early return of natural erections." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
162. Rajpurkar A, Dhabuwala CB. "Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice." J Urol 170:159-163, 2003.
163. Ralph DJ, Minhas S. "The management of Peyronie's disease." Br J Urol 3:208-215, 2004.
164. Ralph DJ, Wylie KR. "Ejaculatory disorders and sexual function." Br J Urol 95:1181-1186, 2005.
165. Ravipati G, et al. "Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease." Cardiol Rev 15:76-86, 2007.
166. Renshaw DC. "Coping with an impotent husband." Ill Med J 159:29-35, 1981.
167. Rivera P, et al. "Use of paroxetine on demand in premature ejaculation." Actas Urol Esp 29:387-389, 2005.
168. Rosano GM, et al. "Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk." Eur Urol 47:214-222, 2005.
169. Rosen R, et al. "Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7)." Eur Urol 44:637-649, 2003.
170. Rosen RC. "Psychogenic erectile dysfunction: classification and management." Urol Clin N Am 28:269-278, 2001.
171. Rosen RC. "Reproductive health problems in ageing men." Lancet 366:183-184, 2005.
172. Rosen RC, et al. "The premature ejaculation prevalence and attitudes (PEPA) survey: a multinational survey." J Sex Med 1(suppl):57-58, 2004.
173. Rosenberg MT, et al. "Premature ejaculation as reported by the female partners: prevalence and sexual satisfaction survey results from a community practice." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
174. Saad F, et al. "Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome." Andrologia 40:44-8, 2008 (in press).
175. Sadovsky R, Mulhall JP. "The potential value of erectile inquiry and management." Int J Clin Pract 53:601-608, 2003.
176. Salem EA, et al. "Tramadol HCL has promise in on demand use to treat premature ejaculation." Paper presented at the Third Biennial Conference of the Pan Arab Society for Sexual Medicine. Dubai, United Arab Emirates, February 8-11, 2007.
177. Salonia A, et al. "A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation." J Urol 168:2486-2489, 2002.
178. Salvi FM. "Au dela d l'orgasm (Beyond orgasm)" [French]. Pscyhologies 8:58-61, 2006.
179. Samraj GPN, et al. "Current and future strategies for premature ejaculation." Contemp Urol 17(5):12-21, 2005.
180. Schaalma HP, et al. "Sex education as health promotion: what does it take?" Arch Sex Behav 33:259-269, 2004.
181. Schneider T, et al. "Does penile size in younger men cause problems in condom use? A prospective measurement of penile dimensions in 111 young and 32 older men." Urology 57:314-318, 2001.
182. Schubert M, Jockenhovel F. "Late onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects." J Endocrinol Invest 28:23-27, 2005.
183. Schwarz ER, et al. "The effects of chronic phosphodiesterase-5 inhibitor use in different organ systems." Int J Impot Res, 2008, in press.
184. Seftel A. "Testosterone replacement therapy for male hypogonadism, part III: pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents." Int J Impot Res 19:2-24, 2007.
185. Seftel AD, et al. "The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction." J Urol 171:2341-2345, 2004.
186. Seidman SN, Roose SP. "Sexual dysfunction and depression." Curr Psychiatry Rep 3:202-208, 2001.
187. Semans JH. "Premature ejaculation (ejaculation praecox): a new method of therapy." Z Urol 52:381-389, 1959.
188. "Sex education: start discussions early." Mayo Clinic Newsletter, June 7, 2005, http://www. mayoclinic.com.
189. Shabsigh R, et al. "Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries." Br J Urol Int 94:1055-1065, 2004.
190. Shabsigh R, et al. "Health issues of men: prevalence and correlates of erectile dysfunction." J Urol 174:662-667, 2005a.
191. Shabsigh R, et al. "Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials." Br J Urol Int 96:857-863, 2005b.
192. Sharlip ID. "Course: premature ejaculation." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
193. Sighinolfi MC, et al. "Changes in peak systolic velocity induced by chronic therapy with phosphodiesterase type-5 inhibitor." Andrologia 38:84-86, 2006.
194. Singer AJ. "Management options: clinical applications of the Erectile Dysfunction Guideline 2005 Update Panel." Issues Urol 18:85-88, 2006.
195. Sobel RE, et al. "Nonaeteritic anterior ischemic neuropathy in men using sildenafil citrate for erectile dysfunction: a review of >44,800 patients in clinical and observational studies." Paper presented at the American Urological Association Annual Meeting. Atlanta, GA, May 20-25, 2006.
196. Sommer F, et al. "Epidemiology of Peyronie's disease." Int J Impot Res 14:379-383, 2002.
197. Sommer F, Schulze W. "Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase-5 inhibitors." World J Urol 23:385-392, 2005.
198. Son H, et al. "Studies on self-esteem and penile size in young Korean military men." Asian J Androl 5:185-189, 2003.
199. Sotomayar M. "The burden of premature ejaculation: the patient's perspective." J Sex Med 2(suppl):110-114, 2005.
200. Speel TG, et al. "The risk of coronary heart disease in men with erectile dysfunction." Eur Urol 44:366-370, 2003. (Discussion, Eur Urol 44:370-371, 2003.)
201. Sultan C, et al. "Disorders linked to insufficient androgen action in male children." Human Reprod Update 7:314-322, 2001.
202. Susman ED. "Vardenafil improves satisfaction among men with premature ejaculation." paper presented at the American Urological Association Annual Meeting. San Antonio, TX, May 23, 2005.
203. Syropoulos E, et al. "Size of external genital organs and somatometric parameters among physically normal men younger than 40 years old." Urology 62:201-204, 2003.
204. Talalaj J, Talalaj S. The Strangest Sex: Ceremonies and Customs. Melbourne, Australia: Hill of Content, 1994.
205. Thompson IM, et al. "Association of erectile dysfunction and subsequent cardiovascular disease." J Urol 175(suppl 4), abstract 1333, 2006.
206. Tornehl CK, et al. "Peyronie's disease: individualizing the surgical approach." Contemp Urol 16(6):34-35, 2004.
207. Travison TG, et al. "The natural progression and remission of ED: results from the Massachusetts Male Aging Study." J Urol 177:241-246, 2007.
208. Turnbull JM, Weinberg PC. "Psychological factors involved in impotence: a review of the literature." J Androl 4:59-66, 1983.
209. Uckert S. "Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future." Eur Urol, 2008, in press.
210. University of South Carolina. "Premature ejaculation: out of the dark ages and into the 21st century." Urol Times 33, June 1, 2005 http://www.urologytimes.com.
211. Vicari E, et al. "Incidence of extragenital vascular disease in patients with erectile dysfunction of arterial origin." Int J Impot Res 17:277-282, 2005.
212. Vignozzi L, et al. "Testosterone and sexual activity." J Endocrinol Invest 28:39-44, 2005.
213. Virag R. "Intracavernous injections and new medical treatments of impotence." Rev Med Interne 8(suppl 1):31-35, 1997.
214. Waknine Y. "Medscape alert: reports of sudden vision loss added to labeling for Viagra, Cialis, Levitra." Medscape Today, July 8, 2005, http://www.medscape.com/ viewarticle/508112.
215. Waldinger MD, et al. "Familial occurrence of primary premature ejaculation." Psychiatr Genet 8:37-40, 1998.
216. Waldinger MD, et al. "On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and subsequent solutions." J Sex Med 2:121-131, 2005.
217. Waldinger MD, Schweitzer DH. "Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation, part III: proposal for DSM-V and UCD-II." J Sex Med 3:693-705, 2006.
218. Webster LJ, et al. "Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial." Arch Intern Med 164:514-520, 2004.
219. Weinsaft JW, et al. "Effects of tadalafil on myocardial blood flow in patients with coronary artery disease." Coron Artery Dis 17:493-499, 2006.
220. Wensing G, et al. "Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects." Int J Clin Pharmacol Ther 44:216-224, 2006.
221. Wespes E, et al. "Sildenafil non-responders: haemodynamic and morphometric studies." Eur Urol 48:136-139, 2005.
222. Wessells H, et al. "Complications of penile lengthening and augmentation seen at one referral center." J Urol 155:1617-1620, 1996a.
223. Wessells H, et al. "Penile length in the flaccid and erect states: guidelines for penile augmentation." J Urol 156:995-997, 1996b.
224. Whitehead ED, Kyde BJ. "Diabetes-related impotence in the elderly." Clin Geriatr Med 6:771-795, 1990.
225. Wright PJ. "Comparison of phosphodiesterase type 5 (PDE-5) inhibitors." Int J Clin Pract, 2008, in press.
226. Wylie KR. "Treatment outcome of brief couple therapy in psychogenic male erectile disorder." Arch Sex Behav 26:527-545, 1997.
227. Wylie KR, Eardley I. "Penile size and the small penis syndrome." Br J Urol Int 99:1449-1455, 2007.
228. Wyllie MG. "ADAM and the andropause." Br J Urol Int 91:883-885, 2003.
229. Wyllie MG. "Libido and desire: join the club." Br J Urol Int 92:323-325, 2005.
230. Yates AJ, et al. "Sex- and age-related differences in ceramide dihexosides of primary human brain tumors." Lipids 34:1-4, 1999.
231. Young JM, et al. "Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial." J Androl 25:310-318, 2005.
232. Zhang Y, et al. "Sildenafil citrate treatment for erectile dysfunction after kidney transplantation." Transplant Proc 37:2100-2103, 2005.